Molecular mechanisms in hypertension
著者
書誌事項
Molecular mechanisms in hypertension
Taylor & Francis, 2006
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Authoritative and insightful, this important text provides an update on the latest advances in the areas of biomedical research that are at the interface of science and clinical medicine, where new discoveries in genetics, molecular and cell biology are not only enhancing our understanding of the etiology and progression of disease but are finding application in the development of new drugs or the implementation of new kinds of therapy. Reviewing current knowledge of the mechanisms contributing to hypertension, an internationally renowned team of contributors highlights developments across a broad range of disciplines and provides an overview of the advances in biomedical research that have a direct bearing on current clinical studies. A key work in its field, this text will have broad appeal to clinical cardiologists, vascular medicine specialists, and internists, as well as members of the cardiovascular research community and pharmaceutical and biotechnology industries.
目次
Part I: Renin / Angiotnsin /Aldosterone Systems. Biology of AII (Synthesis, Degradation, Measurement, Fragments and A1-7, AIV, ACE2, Inflammation, Coagulation, Angiogenesis). Actions of AII. Actions of Aldsterone. Biology of Renin/Prorenin/Renin Exon 1A/Direct Renin Action, Renin Synthesis. Circulating RAAS. Tissue RAASs Part II: Renal Mechanisms in Hypertension. Pressure Naturesis. Intraglomerular Pressure and Nephron Loss . Nephron Number and BP. Renal Prostaglandins/Depressors and BP. Role of Dopamine. Modulator and Non-Modulator Hypertension. TGF and BP. Renal Causes of Secondary Hypertension. ACE Inhibitor Prevention of Hypertension. Other Mechanisms Part III: Endocrine Hypertension. Adrenocortical Hypertension. Adrenergic Nervous System. Pheochromocytoma. Other Endocrine Causes of Hypertension Part IV: Non-Ras Peptides. Vasopressin and Neuropeptide Y, Calcitonin GRP, Leptin. Natriuretic Factors. Endothelin. Kinins/ACE Substrates Part V: Secondary Messengers and the Sequelae of Hypertension. Signal Transduction. Regulation of Blood Flow (incl TGF). Vascular Distensability, Pulse Pressure, and Vascular Pathology. Myogenic Regulation and BP. Regression of Vascular Hypertrophy. Left Ventricular Hypertrophy Onset/Regression/Remodeling/Fibrosis. Nitric Oxide/Oxidative Stress/Endothelial (Dys)Function. Prostaglandins, Lypoxigenase Products and BP Control. Endogenous Na/K ATPase Inhibitors Part VI: Genomics, Proteomics and Hypertension. Gene Regulation, Hypertension, Hypertensive Sequelae. Genomic Microarrays and Hypertension. Transgenic and Knock-Out Models of Hypertension. Application of Antisense and Sirna to the Study of Hypertension. Heritable Monogenic Forms of Hypertension (Liddle's etc, Laidlaw's etc) 39. Genetics of Hypertension. Gene Therapy and Hypertension. Proteomics and Hypertension. The Proteosome and the Development of Hypertensive Sequelae. Apoptosis and the Sequelae of Hypertension 44. Stem Cells and Cardiovascular Structure Part VII: Other Issues. Sodium and Potassium in Hypertension. Divalent Cations/ Hypertension. Birthweight and Hypertension. Baroreflexes
「Nielsen BookData」 より